No Data
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here Is What You Need to Know
Gilead Sciences: A Balanced Hold Rating Amidst Growth Prospects and Market Challenges
Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD) and Premier (PINC)
Wells Fargo Maintains Gilead Sciences(GILD.US) With Hold Rating, Maintains Target Price $78
Gilead Sciences to Present at Upcoming Investor Conferences